These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22578383)

  • 1. Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.
    Yuan Y; Kasar S; Underbayev C; Vollenweider D; Salerno E; Kotenko SV; Raveche E
    Mol Immunol; 2012 Sep; 52(2):61-70. PubMed ID: 22578383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.
    Liu Z; Bethunaickan R; Huang W; Lodhi U; Solano I; Madaio MP; Davidson A
    Arthritis Rheum; 2011 Jan; 63(1):219-29. PubMed ID: 20954185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.
    Liu Z; Bethunaickan R; Huang W; Ramanujam M; Madaio MP; Davidson A
    J Immunol; 2011 Aug; 187(3):1506-13. PubMed ID: 21705616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice.
    Haas KM; Watanabe R; Matsushita T; Nakashima H; Ishiura N; Okochi H; Fujimoto M; Tedder TF
    J Immunol; 2010 May; 184(9):4789-800. PubMed ID: 20368280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.
    Pan Y; Jia T; Zhang Y; Zhang K; Zhang R; Li J; Wang L
    Int J Nanomedicine; 2012; 7():5957-67. PubMed ID: 23233803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
    Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
    Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice.
    Mathian A; Gallegos M; Pascual V; Banchereau J; Koutouzov S
    Eur J Immunol; 2011 Mar; 41(3):863-72. PubMed ID: 21312191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
    Pau E; Chang NH; Loh C; Lajoie G; Wither JE
    Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
    Xu L; Wang L; Shi Y; Deng Y; Oates JC; Kamen DL; Gilkeson GS; Wang F; Zhang M; Tan W; Tsao BP
    Arthritis Rheumatol; 2022 Mar; 74(3):496-507. PubMed ID: 34569195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ly108 expression distinguishes subsets of invariant NKT cells that help autoantibody production and secrete IL-21 from those that secrete IL-17 in lupus prone NZB/W mice.
    Tang X; Zhang B; Jarrell JA; Price JV; Dai H; Utz PJ; Strober S
    J Autoimmun; 2014 May; 50():87-98. PubMed ID: 24508410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Yaa locus and IFN-α fine-tune germinal center B cell selection in murine systemic lupus erythematosus.
    Moisini I; Huang W; Bethunaickan R; Sahu R; Ricketts PG; Akerman M; Marion T; Lesser M; Davidson A
    J Immunol; 2012 Nov; 189(9):4305-12. PubMed ID: 23024275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-ErbB2 dual kinase inhibitor lapatinib decreases autoantibody levels and worsens renal disease in Interferon α-accelerated murine lupus.
    Gallo PM; Chain RW; Xu J; Whiteman LM; Palladino A; Caricchio R; Costa-Reis P; Sullivan KE; Gallucci S
    Int Immunopharmacol; 2024 Oct; 140():112692. PubMed ID: 39079344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble human CD83 ameliorates lupus in NZB/W F1 mice.
    Starke C; Steinkasserer A; Voll RE; Zinser E
    Immunobiology; 2013 Nov; 218(11):1411-5. PubMed ID: 23886695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibody repertoire analysis in normal and lupus-prone mice.
    Starobinski M; Lacour M; Reininger L; Izui S
    J Autoimmun; 1989 Oct; 2(5):657-74. PubMed ID: 2803476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.
    Lourenço EV; Liu A; Matarese G; La Cava A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10637-42. PubMed ID: 27588900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
    Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
    Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.